Iskra Pusic, MD, Washington University in St. Louis, St. Louis, MO, talks on ST2 and REG3α, the two main biomarkers used to predict acute graft-versus-host disease (GvHD). These two biomarkers can be combined using the Mount Sinai Acute GVHD International Consortium (MAGIC) probability (MAP) algorithm to determine the probability of developing acute GvHD even before the onset of any clinical symptoms. This interview took place at the 4th Annual Meeting of the International Academy for Clinical Hematology (IACH), which took place virtually in 2021.

свернуть